Premium: Like a Daydream Out of a Science Fiction Novel
Gender: A Wider Lens
Sasha Ayad and Stella O'Malley
4.6 • 961 Ratings
🗓️ 24 February 2024
⏱️ 3 minutes
🧾️ Download transcript
Summary
The significance of technological and scientific advancements in medicine is unquestionable. However, it prompts a critical examination of the appropriate limits when conducting experiments to uncover treatments leading to optimal outcomes. Experimentation necessarily entails risks, and achieving medical progress often involves interventions with potential dangers and unknown outcomes. Striking the right balance between advancing medical knowledge through experimental procedures and the imperative to safeguard patient health is a complex challenge. Ethical considerations must guide the pursuit of innovation to ensure that progress is achieved responsibly and with due regard for the well-being of patients.
In this bonus episode for premium subscribers, Dr. Eithan Haim draws a compelling distinction between the therapeutic justification underpinning effective life-saving medical treatments which may exhibit high mortality rates during their experimental phases. He cites the Left Ventricular Assist Device (LVAD) as a prime example of this. In his analysis, he contrasts these kinds of successful interventions with historical medical practices like bloodletting and lobotomies, which proved unsuccessful in addressing psychological issues through physiological solutions. He highlights parallels to in gender medicine, expressing reservations about the potential consequences of misguided medical interventions.
Watch our full length episode with Dr. Eithan Haim: https://www.widerlenspod.com/p/episode-151
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Gender A Wider Lens exclusive content. If you're a free listener, what you're about to hear is a preview of a bonus episode for our paid sub-stack subscribers. |
| 0:11.0 | If you'd like to hear the rest, go to widerlands pod.com and sign up for any of our paid membership |
| 0:16.8 | options. |
| 0:17.8 | And to all of our premium and founding member subscribers, thank you for the support. And here's the bonus conversation. |
| 0:27.0 | So we're back here with Aetonheim |
| 0:30.0 | and we're talking about, well, we started talking about the kind of tension in medicine between making |
| 0:37.5 | progress with things that are initially experimental and kind of risky, and the need to preserve patients' health. |
| 0:45.3 | And I don't know, I thought this was an interesting question |
| 0:48.0 | and it kind of makes me think about all of the dangerous things |
| 0:51.8 | doctors have done in the past when they're developing a new treatment or a new procedure or whatever. |
| 0:57.0 | So do you have any thoughts about that? |
| 0:59.0 | Yeah, absolutely. You know, it's such a good question, right? |
| 1:03.3 | Because there has to be some therapeutic rationale |
| 1:07.8 | behind what you're doing. |
| 1:09.3 | So I was at Baylor College of Medicine, |
| 1:12.1 | and this was one of the most famous programs in the country |
| 1:15.0 | for heart surgery. |
| 1:16.6 | There was a surgeon by the name of Bud Frazier who is an absolute legend. |
| 1:22.8 | He had developed something called |
| 1:25.4 | the Left Ventricular Assist device in Elbad. |
| 1:29.0 | So it's like a artificial heart. |
| 1:31.8 | And when he was initiating the research and development of this device in the early days, you know, the 80s 90s, I mean you would have a mortality rate that was very very high. You know I I remember the numbers |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Sasha Ayad and Stella O'Malley, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Sasha Ayad and Stella O'Malley and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

